Your browser doesn't support javascript.
loading
Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study.
Luke, Jason J; Ghate, Sameer R; Kish, Jonathan; Lee, Choo Hyung; McAllister, Lindsay; Mehta, Sonam; Ndife, Briana; Feinberg, Bruce A.
Afiliación
  • Luke JJ; Hematology & Oncology (Cancer), University of Chicago Comprehensive Cancer Center, Chicago, IL 60637, USA.
  • Ghate SR; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Kish J; Cardinal Health Specialty Solutions, Dublin, OH 43017, USA.
  • Lee CH; Cardinal Health Specialty Solutions, Dublin, OH 43017, USA.
  • McAllister L; Cardinal Health Specialty Solutions, Dublin, OH 43017, USA.
  • Mehta S; Cardinal Health Specialty Solutions, Dublin, OH 43017, USA.
  • Ndife B; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Feinberg BA; Cardinal Health Specialty Solutions, Dublin, OH 43017, USA.
Future Oncol ; 15(25): 2933-2942, 2019 Sep 01.
Article en En | MEDLINE | ID: mdl-30799646
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidinas / Azetidinas / Vemurafenib / Inmunoterapia / Melanoma Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidinas / Azetidinas / Vemurafenib / Inmunoterapia / Melanoma Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos